Neurological complications – Page 3 – Communicable Diseases Research

Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis

소아 및 장기 코로나의 다기관 염증 증후군: SARS-CoV-2 바이러스 초항원 가설

Article

Published on 2022-07-072022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료기술,

Miller-Fisher syndrome associated with SARS-CoV-2: a case report

SARS-CoV-2와 관련된 Miller-Fisher 증후군: 사례 보고

Case Reports

Published on 2022-07-012022-09-11
Journal: Microbes and infection [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

[키워드] areflexia artificial Artificial respiration Ataxia ataxic ataxic gait Care Case report COVID COVID-19 infection CSF analysis Diagnosis dysfunction early administration examination facial Fisher syndrome Guillain-barrè syndrome Immune-mediated immunoglobulins immunological increasingly Infection intensive care unit intravenous Intravenous immunoglobulins level 2 life-threatening Mild Miller–Fisher syndrome nasal oxygen Neurological complications Neuropathy ophthalmoplegia oxygen Oxygen therapy Patient presenting Prognosis required respiratory Respiratory failure SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections supported syndrome therapy Treatment triad variant weakness
[DOI] 10.1016/j.micinf.2022.104954 PMC 바로가기 [Article Type] Case Reports

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research

K18- 및 CAG-hACE2 형질전환 마우스 모델 및 SARS-CoV-2: 신경변성 연구에 대한 시사점

Review

Published on 2022-06-282022-09-11
Journal: Molecules [Category] COVID19(2023년), SARS, 유전자 메커니즘,

[키워드] absence ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antiviral drug Autopsy Brain brain regions brain tissue CAG-hACE2 transgenic mice caused cells Central nervous system Confusion Consequences coronavirus COVID-19 COVID-19 patient COVID-19 patients Cytokines demonstrated develop direct infection disorder disorders dissect Encephalitis entry receptor enzyme evaluate glial cell global pandemic hACE2 helping human Angiotensin-converting enzyme Human brain increase in infected with SARS-CoV-2 Inflammation K18 K18-transgenic mice leukocyte leukocyte infiltration life manifestation mechanism Meningitis Mental Model molecular mouse Mouse models mucosa neuroinvasion neurological Neurological complication Neurological complications neuronal neurons olfactory Patient periphery pro-inflammatory cytokine pro-inflammatory cytokines provoke Quality of life reported responses robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 neuroinvasion severe acute respiratory syndrome Coronavirus suggested survivor therapy transgenic Transgenic mouse Vaccine development
[DOI] 10.3390/molecules27134142 PMC 바로가기 [Article Type] Review

Posterior reversible encephalopathy syndrome – A pathology that should not be overlooked in the era of COVID-19

후두 가역성 뇌병증 증후군 - 코로나19 시대에 간과해서는 안 될 병리학

Case Reports

Published on 2022-06-012022-09-11
Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Antibiotics Aphasia Autoimmune diseases blindness Case report cause Computed tomography coronavirus coronavirus disease Coronavirus disease 2019 cortical cortical blindness Corticosteroid Corticosteroids cough COVID-19 delta variant Department described determine diagnosed with COVID-19 Diagnosis dominant drugs Dyspnea eclampsia Emergency emergency department Encephalopathy Europe exhibiting exposure to Fever full recovery general practitioner generalized tonic-clonic seizures had no hypertensive Immediate Infectious disease Infectious diseases Invasion knowledge lobes material medical history MRI nervous system neurological Neurological complication Neurological complications Neurological symptom Neurological symptoms occipital Organ failure outcome pathology Patient patients with COVID-19 Pneumonia Posterior Posterior reversible encephalopathy syndrome PRES presenting radiological receiving renal resolved SARS-CoV-2 SARS-CoV-2 pneumonia secondary to Seizures Sepsis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe SARS Shortness of breath Symptom syndrome Thoracic Treatment variant
[DOI] 10.1016/j.ajem.2022.03.005 PMC 바로가기 [Article Type] Case Reports

Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer’s dementia

입원한 COVID-19 환자와 정상 인지, 경도 인지 장애 또는 알츠하이머 치매가 있는 비 COVID-19 환자의 혈청 신경퇴행성 바이오마커 비교

Article

Published on 2022-05-012022-09-11
Journal: Alzheimer's & dementia : the journal of the Alzhei [Category] MERS, 바이오마커,

[키워드] Acidic Alzheimer's disease amyloid beta Biomarker Biomarkers Cognitive impairment Complication Control correlated COVID COVID patient Covid patients COVID-19 COVID-19 patient Dementia died discharge home discharged home disease elevated Encephalopathy GFAp Glial fibrillary acidic protein hospitalized COVID-19 patient hospitalized COVID-19 patients In-hospital In-hospital death light chain marker Mild Mortality neurodegeneration neurodegenerative neurofilament light chain Neurological complications outcome Patient phosphorylated Protein SARS-CoV-2 serum severity significantly significantly lower subject survival tau. UCHL1
[DOI] 10.1002/alz.12556 PMC 바로가기 [Article Type] Article

The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design

Research article

Published on 2022-05-012022-10-05
Journal: Contemporary clinical trials [Category] COVID19(2023년), SARS, 신약개발, 임상, 치료법, 치료제,

[키워드] amantadine antiinflammatory Antiviral Asymptomatic caused clinical clinical condition clinical trial combating complex Course COVID-19 COVID-19 symptom Demonstrating develop diagnosed with COVID-19 disease early treatment Effect Effects Efficacy and safety Hospitalized Hypothesis Infection Intensive long-COVID mortality rate Neurological complication Neurological complications organ dysfunction outcome pandemic Patient patients Placebo Poland positive prevention of COVID-19 progression protocol recruitment reduction in Region Respiratory failure risk factor SARS-COV-2 infection severity subject symptomatic syndrome the disease the SARS-CoV-2 virus therapy Treatment Trial worsening
[DOI] 10.1016/j.cct.2022.106755 [Article Type] Research article

Treating the body to prevent brain injury: lessons learned from the coronavirus disease 2019 pandemic

뇌 손상을 예방하기 위한 신체 치료: 2019년 코로나바이러스 전염병에서 배운 교훈

Review

Published on 2022-04-012022-09-11
Journal: Current opinion in critical care [Category] Coronavirus, COVID19(2023년), SARS, 치료기술,

Small fiber neuropathy associated with SARS-CoV-2 infection

Article

Published on 2022-04-012023-07-07
Journal: Muscle & nerve [Category] COVID19(2023년),

[키워드] long-haul COVID-19 symptoms Neurological complications Post-acute COVID-19 syndrome SARS-CoV-2 small fiber neuropathy
[DOI] 10.1002/mus.27458 PMC 바로가기

Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines – where do we stand?

Review

Published on 2022-03-252023-07-08
Journal: Reviews in the neurosciences [Category] COVID19(2023년),

[키워드] Cerebrovascular complications COVID-19 vaccines Demyelinating diseases Neurological complications SARS-CoV-2
[DOI] 10.1515/revneuro-2022-0006 [Article Type] Review

Pneumococcal meningitis and COVID-19: dangerous coexistence. A case report

폐렴 구균 수막염 및 Covid-19 : 위험한 공존.사례 보고서

Case Reports

Published on 2022-02-232022-09-10
Journal: BMC Infectious Diseases [Category] COVID19(2023년), Fulltext, MERS, SARS, 치료기술, 치료제,

[키워드] anti-inflammatory agents anti-inflammatory treatment Antibiotic therapy Bacteria Bacterial bacterial pathogen Bacterial pathogens bleeding Blood C-reactive protein Case report ceftriaxone cerebrospinal fluid Co-infection Combination Computed tomography consciousness Corticosteroid Corticosteroids Course COVID-19 COVID-19 patient COVID-19 patients COVID-19 pneumonia Culture detect Deterioration Dexamethasone diagnosed diagnosed with COVID-19 died Diseases disorder excluded fungal infections general condition Health high-risk population Hospitalization Human Infection infections initial initial treatment intubation invasive Laboratory parameters mechanical ventilation Meningitis Mortality multiple organ failure Neurological complications Organ failure oxygen Oxygen therapy pathogen Pathogens Patient patients pneumococcal pneumococcal meningitis pneumococcal sepsis Pneumonia pneumoniae procalcitonin required respiratory Respiratory disease respiratory disorder respiratory disorders Respiratory failure responsible risk SARS-CoV-2 SARS-COV-2 infection Secondary infection secondary infections Sepsis sputum Streptococcus pneumoniae subsequent Symptom the disease the patient Tocilizumab Treatment Urine Vascular Viral viral infection viral pathogen
[DOI] 10.1186/s12879-022-07156-1 PMC 바로가기 [Article Type] Case Reports